Kidney disease decisions — 2025

The Board denied service connection for the Veteran's cause of death, finding that it was less likely than not that his death was caused by his service.

The appeal was denied because the Veteran's request for a Higher-Level Review was untimely.

The Board remands the claims for service connection for anxiety, neurobehavioral effects, Barrett's esophagus, a kidney condition, and a liver condition due to exposure to contaminated water at Camp Lejeune.

The Board remands the claim for service connection for a kidney condition to obtain an adequate medical opinion regarding its etiology, including considering toxic exposure risk activities (TERA) participation.

The Board remands the claim for a medical opinion to determine if the Veteran's residuals of kidney contusion contributed to his chronic renal failure.

The Board remands the claims for service connection for a respiratory disorder and kidney cancer to correct duty to assist errors that occurred prior to the September 2023 decision on appeal.

The Board granted a 50 percent rating for the veteran's unspecified anxiety disorder with opioid use disorder and denied a temporary total rating for hospitalization in February 2023 and March 2023. The remaining service connection claims were remanded.

The Board remands the issue of entitlement to service connection for residuals of renal cell carcinoma due to a pre-decisional duty-to-assist error, requiring a VA examination.

The Board denied service connection for chronic kidney disease, finding that the evidence does not support a causal link between the Veteran's in-service exposure to contaminated water at Camp Lejeune and his current condition.

The Board remands the claim for a new VA examination to determine the full impact of the Veteran's lupus disability, including musculoskeletal residuals.

The Veteran was granted an initial 100 percent evaluation for cystic kidney disease, clear cell renal cell carcinoma and an effective date of November 29, 2021, but no earlier.

The Board granted service connection for chronic renal disease, finding a balance of favorable and unfavorable evidence supports the claim.

The Board remands the claim for service connection for polycystic kidney disease to obtain additional evidence, including private treatment records from a Dutch hospital or clinic and VA treatment records.

The Board denied service connection for gastroesophageal reflux disease and chronic kidney disease as the evidence did not support a finding that these conditions began during active service or were otherwise related to an in-service injury, event, or disease.

The Board remands all issues on appeal for additional development, including verification of potential exposure to herbicide agents and other chemicals, as well as obtaining any relevant treatment records.

The Board denied the veteran's claim for service connection for chronic kidney disease as there is no evidence that it manifested in service or within one year thereafter, and it is not otherwise related to service.

The Board granted service connection for chronic kidney disease, finding it to be related to the Veteran's service-connected ischemic heart disease and Type II diabetes mellitus.

The Board remands the claim for a VA kidney examination to determine if there is any recurrent kidney disability related to service, including exposure to Camp Lejeune contaminated water.

The Board denied a higher rating for kidney stones and erectile dysfunction, but granted a separate rating of 20 percent for voiding dysfunction/urinary leakage.

The Board denied the Veteran's claim for compensation under 38 U.S.C. § 1151 for a left kidney removal, finding that it was not caused by carelessness, negligence, lack of proper skill, error in judgment, or similar instance of fault due to VA treatment and was not caused by an event that was not reasonably foreseeable.